you really think they will limit to $6.5m - i am thinking much larger numbers given the huge cost of maintaining this operation including R&D and wages/bonuses etc.
really need to get that FDA approval ASAP then one can be in a better position to determine how much market share may be able to be obtained and benefits $wise from that. so all in all will still be some time IMO before anything will eventuate and $'s, if any, start to come in - so till then imo this dilution will be quite large. these people won't want to go to market again for CR for some time imo and they will want their positions cemented for a while longer. all imo
Add to My Watchlist
What is My Watchlist?
